GALVUSMET T. 50/850MG 60S

GALVUSMET T. 50/850 mg Tablets – 60 Tablets
Active Ingredients: Vildagliptin 50 mg / Metformin 850 mg
Therapeutic Class: Oral Antidiabetic – DPP-4 Inhibitor + Biguanide

Description:
GALVUSMET combines vildagliptin, a DPP-4 inhibitor that increases insulin release and lowers glucagon levels, with metformin, which decreases glucose production in the liver and improves insulin sensitivity. This combination effectively controls blood sugar in adults with type 2 diabetes.

Indications:

• Management of type 2 diabetes when diet, exercise, and monotherapy are insufficient.

• Can be used as dual therapy or as add-on to other antidiabetics.

Dosage:

• Typically one tablet twice daily with meals.

• Dosage adjusted according to patient response and tolerance.

Contraindications:

• Type 1 diabetes

• Diabetic ketoacidosis

• Severe renal or hepatic impairment

• Hypersensitivity to active substances

Warnings:

• Monitor kidney function regularly

• Risk of lactic acidosis (rare but serious)

• Use with caution in patients with liver or heart disease

• Not recommended during pregnancy or breastfeeding

Side Effects:

• Gastrointestinal discomfort (nausea, diarrhea)

• Hypoglycemia (especially with sulfonylureas or insulin)

• Headache

• Rare: lactic acidosis

Storage:
Store below 30°C in a dry place away from sunlight.